The Clayco Foundation

The Clayco Foundation is a tax exempt 501(c)(3) entity that supports multiple charitable organizations in the communities where Clayco is actively engaged in business. 

At Clayco, our culture is based on building more than just structures. It is built on the foundation that respect for all with a perseverance to genuinely leave a positive impact on our world is of the upmost importance. 

Although The Clayco Foundation supports numerous charitable organizations, all of the donations raised through Illumination 2016 will directly fund research for Retinal Vasculopathy with Cerebral Leukodystrophy (RVCL). A very rare, genetic condition that affects the central nervous system. 

Creating the best mouse model system to determine how TREX mutations disrupt normal cellular function, understand how it works (pathophysiology) in a living system, and screen for the most effective therapeutic agents

Collaborating with pharmaceutical companies and the FDA to gain access to or produce a drug called aclarubicin (ACM) for human use. 

Leading collaboration of four key research groups: Washington University in St. Louis, University of California, National Institutes of Health, and University of Texas Southwestern.

Planning a scientific symposium to provide enhanced data sharing, discussion of results and expansion of our knowledge base with researchers in the U.S. and globally. 

Systemic Lupus Erythematosus

Diabetic Retinopathy

Aging disorders

Blood vessel deterioration disorders (vasculopathies)

As well as other related diseases